Differences in the ability to generate type 1 T helper cells need not determine differences in the ability to resist mycobacterium tuberculosis infection among mouse strains

Journal of Infectious Diseases

Volumn 199, Issue 12, 2009, Pages 1790-1796

  Jung, Yu Jin ^a   Ryan, Lynn ^b   Course, Ronald La ^b   North, Robert J ^b  

^a Kangwon National University   (South Korea)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE;

AIRBORNE INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; INFECTION RESISTANCE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TUBERCULOSIS; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LUNG; LUNG TUBERCULOSIS; MACROPHAGE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; TH1 CELLS; TRANSCRIPTION, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 67650499229     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599092     Document Type: Article

References (34)

1. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109:205-17.
2. Pierce CH, Dubos RJ, Scheafer WB. Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med 1953; 97:189-205.
3. Medina E, North RJ. Evidence inconsistent with a role for the Beg gene (Nramp'l ) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med. 1996; 183:1045-51.
4. Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect: Immun 2001; 69:2666-74.
5. Yan BS, Pichugin AV, Jobe O, et al. Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1 -mediated mechanism of innate immunity. J Immunol 2007; 179:6919-32.
6. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004; 22:599-623.
7. Medina E, North RJ. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 1998; 93:270-4.
8. Chackerian AA, Behar SM. Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis (Edinb) 2003; 83:27985.
9. Kramnik I, Dietrich WF, Demant P, Bloom BR. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2000; 97:8560-5.
10. Mitsos LM, Cardon LR, Fortin A, et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun 2000; 1:467-77.
11. Mitsos LM, Cardon LR, Ryan L, et al. Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication, in the lungs. Proc Natl Acad Sci USA 2003; 100:6610-5.
12. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999; 180:150--5.
13. Sanchez F, Radaeva TV, Nikonenko BV, et al. Multigenic control of disease severity after virulent Mycobacterium tuberculosis infection in mice. Infect Immun 2003; 71:126-31.
14. Pan H, Yan BS, Rojas M, Shebzukhov YV, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434:767-72.
15. Ehrt: S, Schnappinger D, Bekiranov S, et al. Reprogramrning of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001; 194:1123--40.
16. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992; 175:1111-22.
17. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001; 193:271-80.
18. Jung YJ, Ryan L, LaCourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005; 201:1915-24.
19. Jung YJ, LaCourse R, Ryan L, North RJ. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J Exp Med 2002; 196:991-8.
20. Boom WH. The role of T cell subsets in Mycobacterium tuberculosis in fection. Infect Agents Dis 1996; 5:73-81.
21. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
22. Kaufmann SH Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002; 61(Suppl 2):ii54-8.
23. Wolf AJ, Desvignes L, Linas B, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node not the lungs. J Exp Med 2008; 205:105-15.
24. Kamath AB, Alt J, Debbabi H, Taylor C, Behar SM. The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice. Infect Immun 2004; 72:6790-8.
25. MacMicking JD, North RJ, LaCourse R, et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94:5243-8.
26. phox-/- mice. Infect Immun 2000; 68:1231-4.
27. Yan BS, Pichugin AV, Jobe O, et al. Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1 -mediated mechanism of innate immunity. J Immunol 2007; 179:6919-32.
28. Majlessi L, Simsova M, Jarvis Z, et al. An increase in antimycobacterial Th1 -cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun 2006; 74:212837.
29. Mittrücker HW, Steinhoff U, Köhler A, et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuber culosis. Proc Natl Acad Sci USA 2007; 104:12434-9.
30. Furcolow ML, Hewell B, Nelson WE. Quantitative studies of the tuberculin reaction: tuberculin sensitivity in relation to active tuberculosis. Am Rev Tuberc 1942; 45:504-20.
31. Al Zahrani K, Al Jahdali H, Menzies D. Does size matter? Utility of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med. 2000; 162:1419-22.
32. Arend SM, Anderson P, van Meijgaarden KE, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect: Dis 2000; 181: 1850-4.
33. Ulrichs T, Anding P, Porcelli S, Kaufmann SH, Munk ME. Increase numbers of ESAT-6- and purified protein derivative-specific gamma interferon producing cells in subclinical and active tuberculosis infection. Infect Immun 2000; 68:6073-6.
34. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357:2017-21.